rs139329616
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP3BP4_StrongBS2
The NM_001126108.2(SLC12A3):c.1732G>A(p.Val578Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,614,214 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001126108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1732G>A | p.Val578Met | missense_variant | Exon 14 of 26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.1732G>A | p.Val578Met | missense_variant | Exon 14 of 26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.1729G>A | p.Val577Met | missense_variant | Exon 14 of 26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.1729G>A | p.Val577Met | missense_variant | Exon 14 of 26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1732G>A | p.Val578Met | missense_variant | Exon 14 of 26 | 1 | NM_001126108.2 | ENSP00000456149.2 | ||
SLC12A3 | ENST00000438926.6 | c.1732G>A | p.Val578Met | missense_variant | Exon 14 of 26 | 1 | ENSP00000402152.2 | |||
SLC12A3 | ENST00000566786.5 | c.1729G>A | p.Val577Met | missense_variant | Exon 14 of 26 | 1 | ENSP00000457552.1 | |||
SLC12A3 | ENST00000262502.5 | c.1729G>A | p.Val577Met | missense_variant | Exon 14 of 26 | 5 | ENSP00000262502.5 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000649 AC: 163AN: 251242Hom.: 0 AF XY: 0.000618 AC XY: 84AN XY: 135822
GnomAD4 exome AF: 0.000232 AC: 339AN: 1461878Hom.: 2 Cov.: 34 AF XY: 0.000235 AC XY: 171AN XY: 727240
GnomAD4 genome AF: 0.000230 AC: 35AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74496
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Uncertain:3
- -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.061%). Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.91 (>=0.6, sensitivity 0.68 and specificity 0.92)]. The variant has been reported as benign without evidence for the classification (ClinVar ID: VCV000225469). Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline. -
not provided Uncertain:1Benign:1
- -
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33348466, 15198479, 30596175, 32884933, 34373523, 25841442, 12112667, 36806220, 10616841, 26770037, 20810575, 22484642, 31305454, 37147621, 36333282, 34604727, 35591852, 20072789) -
SLC12A3-related disorder Uncertain:1
The SLC12A3 c.1732G>A variant is predicted to result in the amino acid substitution p.Val578Met. This variant has been observed in the heterozygous and also the compound heterozygous state in several individuals with Gitelman syndrome (Monkawa et al. 2000. PubMed ID: 10616841; Nozu et al. 2010. PubMed ID: 20810575; Takahashi et al. 2012. PubMed ID: 22484642; Fujimura et al 2018. PubMed ID: 30596175; Table S7 in Kondo A et al 2021. PubMed ID: 34373523). However, in one of the compound heterozygous individuals the c.1732G>A (p.Val578Met) variant also occurred in cis with a SLC12A3 frameshift variant (Reported as c.2543_2544del in Monkawa et al. 2000. PubMed ID: 10616841). This c.1732G>A was also detected with this same frameshift variant in two additional individuals and phase was not determined, but these variants may represent a haplotype allele in certain populations (Reported as c.2537_2538del in Mori T et al 2020. PubMed ID: 33348466 and Miya A. et al. 2019. Medicine. 98:e16408). This variant has also been reported in a multigenerational family with one individual affected with Gitelman Syndrome; however, it was also detected in the compound heterozygous state in an asymptomatic individual (Ishikawa et al. 2020. PubMed ID: 32884933). This variant is reported in 171 of ~283,000 alleles in gnomAD with a frequency of 0.80% in individuals of East Asian descent (http://gnomad.broadinstitute.org/variant/16-56918023-G-A). This variant has conflicting interpretations of likely benign and uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/225469/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at